Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.

Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
复制标题

新型非核苷逆转录酶抑制剂 (RTI) 与 AZT 相结合,可产生针对多重 RTI 耐药 HIV-1 菌株的强协同作用

DOI:
10.3390/molecules23071599
复制
发表时间:
2018-07-02
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
通讯作者:
Jiang S
Jiang S
中科院分区:
其他
文献类型:
--
作者:
Yu F;Li W;Wang L;Dai Y;Lu X;Wang Q;Xie L;Jiang S

文献摘要

参考文献

被引文献

相似文献

逆转录酶抑制剂(RTIs)包括核苷类逆转录酶抑制剂(NRTIs)和非核苷类逆转录酶抑制剂(NNRTIs),是治疗人类免疫缺陷病毒(HIV)感染的重要抗逆转录病毒药物。多重RTI耐药的出现要求开发针对RTI耐药菌株的更有效的治疗剂或方案。在这里,我们证明了叠氮胸苷(AZT)与正在开发的新NNRTI,二芳基吡啶(达帕)-2e,二芳基苯胺(DAAN)-14h,DAAN-15 h的组合,导致了对不同HIV-1毒株感染的强烈协同作用,包括对NRTI和NNRTI耐药的毒株,这表明开发这些新型NNRTI作为HIV/获得性免疫缺陷综合征(AIDS)患者的挽救治疗的潜力。
Reverse transcriptase inhibitors (RTIs), including nucleoside RTIs (NRTIs) and non-nucleoside RTIs (NNRTIs), are critical antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infection. Emergence of multi-RTI resistance calls for the development of more potent therapeutics or regimens against RTI-resistant strains. Here, we demonstrated that combining azidothymidine (AZT) with a new NNRTIs under development, diarylpyridine (DAPA)-2e, diarylanilin (DAAN)-14h, or DAAN-15h, resulted in strong synergism against infection by divergent HIV-1 strains, including those resistant to NRTIs and NNRTIs, suggesting the potential for developing these novel NNRTIs as salvage therapy for HIV/acquired immune deficiency syndrome (AIDS) patients.
DOI: 10.1021/acs.jmedchem.5b01827
发表时间: 2016-04-28
影响因子: 7.3
作者:
Liu, Na;Wei, Lei;Huang, Li;Yu, Fei;Zheng, Weifan;Qin, Bingjie;Zhu, Dong-Qin;Morris-Natschke, Susan L.;Jiang, Shibo;Chen, Chin-Ho;Lee, Kuo-Hsiung;Xie, Lan
通讯作者: Xie, Lan
HIV-1 gp41 靶向融合抑制肽增强 gp120 靶向蛋白介导的 HIV-1 病毒颗粒失活
DOI: 10.1038/emi.2017.46
发表时间: 2017-06-21
影响因子: 13.2
作者:
Qi Q;Wang Q;Chen W;Du L;Dimitrov DS;Lu L;Jiang S
通讯作者: Jiang S
DOI: 10.1128/aac.45.4.1192-1200.2001
发表时间: 2001-04-01
影响因子: 4.9
作者:
Maga, C;Hübscher, U;Spadari, S
通讯作者: Spadari, S
一种新型HIV-1 gp41三方模型,用于合理设计具有改进抗病毒活性的HIV-1融合抑制剂
DOI: 10.1097/qad.0000000000001415
发表时间: 2017-04-24
期刊: AIDS
影响因子: 3.8
作者:
Su, Shan;Wang, Qian;Lu, Lu
通讯作者: Lu, Lu
DOI: 10.1016/j.bmcl.2009.07.080
发表时间: 2009-09-15
影响因子: 2.7
作者:
Tian, Xingtao;Qin, Bingjie;Lu, Hong;Lai, Weihong;Jiang, Shibo;Lee, Kuo-Hsiung;Chen, Chin Ho;Xie, Lan
通讯作者: Xie, Lan